Emiac Technologies Reports Q2FY27 IPO Proceeds Utilization with Zero Deviation
Emiac Technologies Ltd · Others (Uncategorized) · 06 Nov 2026, 10:33 pm
Emiac Technologies Reports Q2FY27 IPO Proceeds Utilization with Zero Deviation CARE Ratings confirmed zero deviation in Emiac Technologies Limited's IPO proceeds utilization for the quarter ended 30th Sep'26. Out of total raised proceeds of ₹31.75 crore, the company utilized ₹7.54 crore during Q2FY27, bringing cumulative deployment to ₹24.90 crore. Key quarterly spending included ₹3.27 crore on IT hardware, software, and cloud hosting, ₹3.09 crore for working capital, and ₹0.69 crore for general corporate purposes. Unutilized funds of ₹6.86 crore remain parked across ICICI Bank fixed deposits and the monitoring account.
Original exchange filing (PDF)
More announcements from Emiac Technologies Ltd
- Notice of Extra-Ordinary General Meeting to be held on Wednesday, 9th December 2026 at 04.00 P.M. · 18 Nov 2026
- Statement of funds utilization of IPO proceeds for the half year ended 30th September, 2026 · 13 Nov 2026
- Outcome of the Board Meeting held on Thursday, November 12, 2026 at 04:00 P.M. · 12 Nov 2026
- Intimation for Appointment of Chief Financial Officer and disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015 · 02 Oct 2026
- Scrutinizer''s Report for the 10th Annual General Meeting held on Monday, 28th September, 2026 at 04: 00 P.M. · 29 Sept 2026
- Outcome of 10th Annual General Meeting held on Monday, 28th September, 2026 at 04:00 P.M. · 29 Sept 2026
- Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 - acquisition of 100% of equity share capital of Emiac Inc., USA, and making Emiac Inc. a wholly owned subsidiary of the company · 25 Sept 2026
- Corrigendum to the 10th Annual Report for the Financial Year 2025-26 in connection with the 10th Annual General Meeting of the Company. This Corrigendum is being issued to rectify certain .... · 23 Sept 2026
